Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
05/2003
05/14/2003EP1309591A2 Substituted pyrazoles
05/14/2003EP1309590A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309564A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309503A1 Spray device
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309332A2 Macrolide formulations for inhalation and methods of treatment of endobronchial infections
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1309315A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor
05/14/2003EP1137399B1 Improvements in or relating to powders
05/14/2003EP1112266B1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
05/14/2003EP1102746B1 Substituted phenylamidines with antithrombotic action
05/14/2003EP0937100B1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof
05/14/2003EP0873330B1 Diarylalkenylamine derivatives
05/14/2003CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity
05/14/2003CN1418214A 4-Hydroxy-1, 8-Naphthyridine-3-carboxamides as antiviral agents
05/14/2003CN1418211A 苯并咪唑衍生物 Benzimidazole derivatives
05/14/2003CN1418197A Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
05/14/2003CN1418195A Therapeutic morpholino-substituted compounds
05/14/2003CN1418194A Amide compounds and use thereof
05/14/2003CN1418193A heterocyclic side chain containing metalloprotease inbibitors
05/14/2003CN1418192A Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/14/2003CN1418191A Novel thiourea derivatives and the pharmaceutical compositions containing thd same
05/14/2003CN1418187A Carboxylic acid derivatives as IP antagonists
05/14/2003CN1418102A 激素替代疗法 Hormone replacement therapy
05/14/2003CN1418096A IL-8 receptor antagonists
05/14/2003CN1418091A Pharmaceutical preparations
05/14/2003CN1416892A Compound medicine tablet of biological bacteria powder for treating dyspneic cough
05/14/2003CN1416883A Pestilence preventing Chinese medicine powder and its prepn
05/14/2003CN1416869A Strong loquat distillate (honeyed) and its prepn
05/14/2003CN1416828A Laryngopharyngitis-treating Chinese medicine and its prepn
05/13/2003US6562988 16-HETE (16-hydroxyeicosatetraenoic acid) analogues such as the methanesulfonamide ester (-CO-NH-SO2-CH3); inhibiting neutrophil adhesion and neutrophil aggregation; treating stroke, inflammatory diseases
05/13/2003US6562851 Antiinflammatory and antiasthmatic agents; inhibitors of alpha4 beta1 mediated cell adhesion
05/13/2003US6562843 For treating disorders ameliorated by a reduction in TNF-alpha production and/or p38 activity, and are therefore useful for treating inflammatory disorders such as rheumatoid arthritis, as well as AIDS-related disorders
05/13/2003US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies
05/13/2003US6562824 Dihydropyridine soft drugs, and related compositions and methods
05/13/2003US6562811 Pyridine derivatives
05/13/2003US6562781 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003CA2127876C Imidazole derivatives and their use as cytokine inhibitors
05/08/2003WO2003038110A2 7118, a human arginine n-methyltransferase family member and uses therefor
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037927A1 Novel protein, its dna and use thereof
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037899A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003WO2003037898A1 Pyrimido [4,5-b] indole derivatives
05/08/2003WO2003037892A1 Compounds useful as reversible inhibitors of cysteine proteases
05/08/2003WO2003037882A1 Heterocyclic retinoid compounds
05/08/2003WO2003037874A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037433A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/08/2003WO2003037385A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037306A2 Inhalation of vapour of therapeutical substances, like e.g. cannabis extract
05/08/2003WO2003037159A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003017929A3 Method for treating bronchial constriction and bronchospasm
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002026223A3 Catecholamine pharmaceutical compositions and methods
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030087957 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
05/08/2003US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1.
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087910 E.g., O-(2-quinolinylmethyl)-N-quinaldoyl-D,L-tyrosine
05/08/2003US20030087904 Xanthine derivatives, such as 3-isobutyl-8-pyrrolidinylxanthine; treating asthma, diarrhea, etc.
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087875 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
05/08/2003US20030087831 1,3,4-Oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
1 ... 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 ... 878